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The uterine expression of the chemokine IL8 increases dramatically with the onset of labour both at term and preterm. The
IL8 promoter contains binding sites for the transcription factors nuclear factor-kappa B (NFκB), activator protein-1 (AP-1), and
CCAAT/enhancer-binding protein (CEBP). In this study we investigated the roles of these transcription factors in IL1B regulation
of the IL8 gene in human myometrium. Using chromatin immune precipitation (ChIP) assay, we showed that each of NFκB,
CEBP, and AP-1 binds to the IL8 promoter upon IL1B stimulation. To examine the relative importance of each site in IL8 gene
expression, site-directed mutagenesis of each of these sites was performed. We found that the NFκB site was essential for basal
and IL1B-stimulated gene expression. Mutation of the AP-1 site reduced both basal and IL1B-stimulated expression but to a lesser
extent. Mutation of the CEBP site had no eﬀect upon basal expression but eliminated the IL1B response. Small interfering RNA
(siRNA) silencing of NFκB abolished the IL8 response to IL1B signiﬁcantly; siRNA against AP-1 reduced it to a lesser extent whilst
knockdownofCEBPenhancedtheresponse.OurdataconﬁrmsacentralandessentialroleforNFκBinregulationofIL8inhuman
myometrium.
1.Introduction
Theonsetoflabourisassociatedwithchangesingeneexpres-
sioninthemyometriumconsistentwithactivationofinﬂam-
matory mediators and leukocyte chemotaxis [1, 2]. The uter-
ine expression of the chemokine IL8 increases dramatically
with the onset of term and preterm labour [3, 4] and is
thought to promote cervical remodelling [5, 6]a n dm y o m e -
trial contractility by promoting neutrophil inﬁltration and
activation [4, 7]. Myometrial IL8 expression is increased by
stretch and the inﬂammatory cytokines in a MAPK- and
NFκB-dependentmanner[8,9].Consistentwiththeseobser-
vations, IL8 expression has been shown to be critically
dependent on a region in its promoter, spanning nucleotides
−1t o−133, which contains binding sites for the transcrip-
tion factors AP-1, CEBP, and NFκB[ 10–13]. The binding
sites are in close proximity to each other and to the coding
region of the gene, forming a transcriptional enhanceosome
(Figure 1(a)). Many researchers have investigated the role
and interaction of these transcription factors in regulating
the IL8 gene and have shown diﬀerent mechanisms of regu-
lation depending on the cell type [13–21]. Studies in repro-
ductive tissues show that NFκB is important in IL1B-driven
IL8 expression in amnion and myometrium [14], AP-1 is
involvedinthestretch-inducedexpressionofIL8,OXTR,and
COX2 in human myometrial and amnion cells [9, 22, 23],
and CEBP has been shown to bind to two diﬀerent regions of
the IL8 promoter and interact with NFκB to regulate the IL8
expression [24].
The marked inﬂammatory inﬁltration of the myome-
trium and cervix associated with human labour is driven
by increased expression of IL8 and other chemokines. The
transcription factors, NFκB, CEBP, and AP-1, have all been
implicated in IL8 expression in various tissues/cell types, but
which actually regulate myometrial IL8 expression remains
unclear. In this study, we have used IL1B stimulation to
mimic labour in order to deﬁne the relative importance of
NFκB, CEBP, and AP-1 in myometrial IL8 expression.2 Mediators of Inﬂammation
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Figure 1: (a) Schematic of the IL8 promoter enhanceosome region. (b) ChIP analysis demonstrates the in vivo binding of NFκBp65, CEBPβ
and d, c-Jun, c-Fos, and H4 to the transcriptional enhanceosome of the IL8 promoter. ChIP assay using antibodies against NFκBp65 and
CEBPβ and -d, c-Jun, and c-Fos was performed in nonstimulated (N/s) and IL1B stimulated conditions. The immunoprecipitates were
subjected to PCR analysis using primer pairs spanning the IL8 promoter transcriptional enhanceosome. The ﬁrst two lanes are “input”
lanes where no immunoprecipitation was performed prior to PCR. The second two lanes contained IgG antibody for immunoprecipitation
(negative controls).
Table 1: Primers used in site-directed mutagenesis.
Construct Forward primer sequence Reverse primer sequence
IL8 mAP-1 5 -GATCTGAAGTGTGATATCTCAGGTTTGCCCTGA-
GGG-3 
5 -CCCTCAGGGCAAACCTGAGATATCACACTTCAG-
ATC-3 
IL8 mκB 5 -GGGCCATCAGTTGCAAATCGTTAACTTTCCTCT-
GAC-3 
5 -GTCAGAGGAAAGTTAACGATTTGCAACTGATGG-
CCC-3 
IL8 mCEBP 5 -GGGCCATCAGCTACGAGTCGTGGAATTTCCTCT-
GAC-3 
5 -GTCAGAGGAAATTCCACGACTCGTAGCTGATGG-
CCC-3 
2.MaterialsandMethods
2.1. Myometrial Cell Culture. Myometrial cells were extract-
ed from biopsies taken at the time of elective caesarean sec-
tion at term with the Ethics Committee approval and patient
consent. None of the patients was in labour or had received
uterotonics or tocolytics. Tissue was minced and digested for
45min in DMEM with 1mg/mL collagenase type IA and
IX (Sigma-Aldrich Corp., St. Louis, MO, USA). Cells were
centrifuged at 400×gf o r1 0 m i na n dg r o w ni nD M E M
with 10% fetal calf serum, L-glutamine, and penicillin-
streptomycin (37◦C and 5% CO2). Cells were serum starved
for 16h before treatment with 1ng/mL IL1B (R&D Systems,
Inc., Minneapolis, MN, USA). Cells were used at passage
three for all experiments.
2.2. Western Blotting. T oo b t a i nw h o l ec e l ll y s a t e s ,c e l l sw e r e
lysed for 20min on ice in radioimmunoprecipitation assay
buﬀer (1% NP-40, 1% Triton, 1% sodium deoxycholate,
0.1% SDS, 150mM NaCl, 10mM Tris, PH 8.0, and
2mM NaF). Protein concentrations were determined using
detergent-compatible protein assay reagents (Bio-Rad Labo-
ratories). Protein samples (50μg) were denatured by boiling
f o r5m i na n dr u no na1 0 %S D S - P A G Ef o r6 0m i na t1 4 0V ,
followed by a transfer to a Hybond ECL nitrocellulose
membrane (Amersham Biosciensces). The membrane was
blocked in 5% milk protein solution over night or for 1 hour,
washed and hybridized with the primary antibody for 1 hour
at room temperature in a fresh blocking buﬀer (1 × PBS, 1%
milk protein and 0.1% Tween-20) containing antibodies for
RELA and CEBPβ (Santa Cruz Biochemicals, SC-8008 and
SC-7962, resp.) or beta actin (Abcam, Ab6276). This process
was repeated with the secondary antibody. The antibodies
were used at 1:1000 dilution. Immunoreactivity was then
visualised using a chemiluminescent substrate for HRP (ECL
plus; Amersham Biosciensces).
2.3. Site-Directed Mutagenesis. The promoter region of the
IL8 gene (−135/+46bp) was ampliﬁed by polymerase chain
reaction, and the fragment was ligated into the luciferase
reporter plasmid pGL2-Basic (Promega, Southampton, UK)
to give the wild-type construct. The mutation of individual
base pairs in plasmid DNA was achieved using the Quik-
Change Site-Directed Mutagenesis Kit (Stratagene, UK)
according to manufacturer’s instructions. The mutagenic
oligonucleotide primers were designed individually and are
shown in Table 1.
2.4. Transient Transfection. Myocytes were grown in 24-well
plates to 80% conﬂuence. Transient transfections were per-
formed using FuGene 6 transfection reagent (Roche, Indi-
anapolis, IN, USA). Cytomegalovirus-Renilla vector (1/10th
of reporter) was used to control for transfection eﬃciency
and cell number. Luciferase reporter vectors containing
either the wild-type IL8 promoter or the mNFκB( m u t a t i o n
of NFκB) or the mCEBP (mutation of CEBP) or the mAP-1Mediators of Inﬂammation 3
(mutation of AP-1) were transfected at 0.2μg/ w e l l .C e l l s
were cultured for a total of 48h (including 24h of IL1B stim-
ulation for half the experiment) followed by harvesting and
analysis with a dual ﬁreﬂy/Renilla luciferase assay (Luclite,
Packard Bell, and Coelenterazine CN Biosciences). Trans-
fections were performed in triplicates. Luciferase/Renilla
activity was measured 48 hours after transfection.
2.5. Chromatin Immunoprecipitation (ChIP). DNA-protein
complexes were crosslinked in situ with 1% formaldehyde.
The cells were lysed, and chromatin was sheared into 200
to 1000 bp fragments by sonication. Antibodies recognizing
the C-terminal of RELA, CEBPβ (Santa Cruz Biochemicals,
SC-8008 and SC-7962 resp.), and acetyl-histone H4 (Upstate
cellsignallingsolutions,06-866)wereused(1:1000dilution)
for immunoprecipitation, and the chromatin fragments con-
taining the crosslinked protein were puriﬁed by immunoab-
sorption and elution from protein A/G beads. The crosslinks
were reversed, and the DNA was puriﬁed using a QIAquick
nucleotide removal kit (QIAGEN Inc., Valencia, CA, USA).
The DNA region crosslinked to the protein was determined
by PCR analysis. PCR was performed using AmpliTaq Gold
DNA polymerase (Applied Biosystems Ltd.). Pre-PCR cycle
was 10min at 95◦C followed by 35 cycles of 95◦C for 1min,
56–60◦Cf o r1 m i n ,a n d7 2 ◦Cf o r1 m i nf o l l o w e db yﬁ n a l
extension at 72◦C for 10min. The primers are shown in
Table 2.
2.6. siRNA Transfection. ON-TARGETplus SMART pool
human NFκBp65, CEBPβ,C E B P δ,c - F o s ,a n dc - J u ns i R N A s
(Dharmacon) were used. SiGLO (Dharmacon) was used as
a positive control, giving a high transfection eﬃciency of
approximately 90%, and ON-TARGETplus nontargeting
pool (Dharmacon) was used as a negative control. The
siRNAs were transfected using DharmaFECT 2 (Dharma-
con) transfection reagent at a ﬁnal concentration of 100nM
according to manufacturer’s instructions. Brieﬂy, cells were
grown to 80% conﬂuence. Two separate tubes were used for
siRNA preparation. Tube one contained the siRNA diluted
in phenol-red-free DMEM, and tube two contained the
transfectionreagentdilutedinphenol-red-freeDMEM.Each
tube was incubated at room temperature for 5min before
mixing the contents of the two tubes. The mixture was
incubated at room temperature for an additional 20min.
Prewarmed DMEM containing 10% FBS and 2mM L-
glutamine,butnoantibioticswerethenaddedtothemixture.
The culture media was removed from the cells, and the cells
were fed with the siRNA mixture. The media was changed
to DMEM containing 10% FBS, 2mM L-glutamine, and
100 U/mL penicillin-streptomycin 24 hours after the trans-
fection. The siRNA transfections were performed at diﬀerent
time courses (12, 24, 48, and 72h and 5, 6, and 7 days).
The changes were of the same pattern at all time points, but
maximal response was observed at 5 days. The cell viability
was monitored closely before harvesting the cells for appro-
priate analysis.
2.7. Enzyme-Linked Immunosorbent Assay (ELISA). At the
end of incubation assays, 1mL of medium was collected and
Table 2: IL8 ChIP primer covering bps −177 to +22.
Forward primer sequence Reverse primer sequence
5 -GAAAACTTTCGT-
CATACTCCG-3 
3 -GAAAGTTTGTGC-
CTTATGGAG-5 
immediately frozen at −80◦C for analysis by IL8 ELISA kit
(Biosource, KHC0081). The IL8 ELISA had a sensitivity of
5pg/mL; the inter- and intra assay variations were 7.8% and
5.3%, respectively. ELISA data were normalised to cellular
protein. Protein concentrations were determined using
detergent-compatible protein assay reagents (Bio-Rad Lab-
oratories).
2.8. Statistical Analysis. Data are expressed as mean ± SEM.
Statistical analysis was performed by ANOVA with the level
of signiﬁcance deﬁned as P<0.05.
3. Results
3.1. IL1B Stimulates Binding of NFκB, CEBP, and AP-1 to the
IL8 Promoter. ChIP studies showed that IL1B induces the
binding of NFκBp65, CEBP and AP-1 to the endogenous IL8
promoter. IL1B stimulated the recruitment of NFκBp65,
CEBPβ,a n d- δ, cFos, and cJun to their respective cis-
elements in the transcriptional enhanceosome at 6hrs
(Figure 1(b)). This was associated with concomitant acety-
lation of H4 at that region of the promoter.
3.2. Site-Directed Mutagenesis Reveals an Essential Role for
NFκBi nt h eR e g u l a t i o no fI L 8i nH u m a nM y o m e t r i u m .A
sequence extending from −135 to +46 which contains the
transcription enhanceosomewasusedasawild-typecontrol.
Site-directed mutagenesis was performed to make three
further constructs with mutations for each of the NFκB,
CEBP, or AP-1 sites individually (Figure 2). Basal luciferase
activity following transient transfection of the wild-type
construct was signiﬁcantly increased by 2-fold upon IL1B
stimulation. In primary human myometrial cells, mutation
of the NFκB site reduced the unstimulated reporter activity
to10%ofthatofthewildtypeandobliteratedtheresponseto
IL1B. Mutation of the CEBP site had no eﬀect on basal pro-
moteractivitybutdidabolishtheresponsetoIL1B.Mutation
of the AP-1 site decreased basal IL8 promoter activity
although a response to IL1B stimulation was retained
(Figure 2).
3.3. Small Interfering RNA (siRNA) Knockdown of NFκB,
CEBP, or AP-1 Demonstrates a Central Role for NFκBi nt h e
Expression of IL8. Knockdown mediated by siRNA against
NFκBp65, CEBPβ, c-Jun, and c-Fos was performed with
proteinexpressionstudiesshowinghighly-speciﬁcandbetter
than 95% gene silencing (Figure 3(a)). The eﬀect of siRNA
knockdowns against NFκBp65, CEBPβ,c - J u n ,a n dc - F o sw a s
measuredonIL8proteinproductionanditsresponsetoIL1B
stimulation (for 24h) using ELISA.4 Mediators of Inﬂammation
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Figure 2: Representation of the IL8 promoter region and the mutations used in this study, as indicated by the underlined nucleotides. mAP-
1: mutation of AP-1. mNFκB: mutation of NFκB and mCEBP: mutation of CEBP binding site. Functional eﬀect of site-directed mutagenesis
of transcription factor binding sites in the IL8 promoter in primary human myometrial cells. Data are presented as mean ± SEM (n = 4). An
Anova test was performed with a Dunnett’s multiple comparison post-test. ∗∗indicates a signiﬁcant diﬀerence of P less than 0.01 compared
to WT promoter.
Silencing of each individual transcription factor had
no eﬀect on basal IL8 protein release into the culture
medium, measured by ELISA. Knock-down NFκBp65 abol-
ished the response to IL1B signiﬁcantly. Knockdown of
CEBPβ increased the response to IL1B by 1.5-fold whilst
c-Jun and c-Fos knockdown reduced the response by half
(Figure 3(b)). Since CEBPδ may also bind to the IL8
promoter (see Figure 1), we repeated the experiment using
siRNA knockdown of CEBPδ which also increased the
response to IL1B by 1.5-fold as with knockdown of CEBPβ
(Figure 3(c)).
4. Discussion
NFκB, CEBP, and AP-1 are important transcription factor
families that are involved in immune and inﬂammatory
f u n c t i o n sa sw e l la si nc e l lg r o w t ha n dd i ﬀerentiation. NFκB,
CEBP, and AP-1 are each expressed in human myometrium,
and their expression is increased in response to the proin-
ﬂammatory cytokine, IL1B. Labour-associated genes such as
PGHS-2, OTR, IL8, IL6, and TNF-α have been shown to
be regulated by either one or a combination of theses tran-
scription factors [14, 16, 20, 21, 24–29].
Targeting activators of inﬂammation has been proposed
as a strategy for prevention or delay of preterm birth and to
improve outcome in preterm neonates. Condon et al. have
demonstrated a central role for NFκB in the onset of term
labour in the mouse, and that inhibition of NFκB can delay
parturition [30]. Drugs that act through inhibition of NFκB
are available. For example, sulfasalazine is a synthetic anti-
inﬂammatory drug comprising 5-aminosalicylic acid (5-
ASA), linked to sulfapyridine, which is routinely used for theMediators of Inﬂammation 5
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Figure 3: (a) siRNA knockdown of p65 (a), CEBPβ (b), and c-Jun (c). (b) The eﬀects of siRNA against NFκBp65, CEBPβ, c-Jun, and c-Fos
on IL8 protein production in a nonstimulated and IL1B-stimulated state. Data is normalised to the nontargeting control. Data are presented
as mean ± SEM (n = 4). An ANOVA was performed with a Dunnett’s multiple comparison post-test. ∗Indicates a signiﬁcant diﬀerence of
P less than 0.05. (c) The eﬀects of siRNA against NFκBp65, CEBPβ, and CEBPD on IL8 protein production in a nonstimulated and IL1B-
stimulated state. Data is normalised to the non-targeting control. Data are presented as mean ± SEM (n = 4). An ANOVA was performed
with a Dunnett’s multiple comparison post-test. ∗Indicates a signiﬁcant diﬀerence of P less than 0.05.
treatment of inﬂammatory bowel disease and rheumatoid
arthritis. This has been shown to inhibit labour-associated
gene expression in cell culture models [31, 32], although
there are currently no animal or clinical studies. In a
mouse model of inﬂammation-induced preterm labour the
cyclopentenone prostaglandin J2, which acts via inhibition
of NFκB, both delays preterm birth and improves pup
survival [33]. Glucocorticoids such as dexamethasone or
prednisolone have well-established anti-inﬂammatory and
immunosuppressive activities through their inhibitory
eﬀects on AP-1 and NFκBp a t h w a y s[ 34] although there is no
evidence that these drugs will delay or prevent preterm birth.
Progesterone, which, when used clinically, can reduce the
risk of preterm labour, has been shown to repress IL1B-
induced expression of NFκB regulated genes in human
amnion and myometrium [35, 36].
In this study, we examined the role of NFκB, CEBP, and
AP-1 in regulation of IL8 expression in human myometrium6 Mediators of Inﬂammation
andusedIL1Btomimictheeﬀectsofinﬂammationseenwith
human labour. We used ChIP to show that IL1B induces the
binding of all three transcription factors to the IL8 promoter.
This is consistent with the observations of Soloﬀ et al. that
IL1B increases both NFκBp65 and CEBPβ binding to the
endogenous IL8 promoter in myometrial cells [24]. Studies
in other cell types have shown diﬀerent patterns of binding.
For example in a study in human conjunctiva epithelial cells
ChIP showed no binding of NFκB, CEBP, or AP-1 alone, but
when immunoprecipitation was performed for both NFκB
and CEBP simultaneously, ChIP showed binding of both
t ot h eI L 8p r o m o t e r[ 37]. Conversely treatment of human
airway smooth muscle cells with tryptase, which mimics
inﬂammation, induced the binding of all three transcription
factors to the promoter [38].
Since we found that, in human myometrial cells all three
transcription factors bound to the IL8 promoter, we consid-
ered two approaches to identify the relative importance of
eachtranscriptionfactorinIL8expression.Firstweusedsite-
directedmutagenesistoalterthebindingsitesforAP1,CEBP,
and NFκB. We found that mutating both the NFκBa n d
AP-1 sites markedly reduced both basal and stimulated IL8
promoter activity. However, mutating the CEBP site did not
changethebasalpromoteractivitybutdidcompletelyinhibit
the IL1B-induced increase in promoter activity. These data
suggestthattheNFκBandAP-1binding sitesareessentialfor
both basal and IL1B-stimulated IL8 expression. In contrast,
it appeared that CEBP binding sites are not important for
basalpromoteractivitybutareessentialfortheIL1B-induced
increase in promoter activity. Using a similar approach in
human amnion and cervical epithelial cells, Elliott et al.
found similar results for the NFκB binding site but found no
eﬀect of mutating the CEBP or AP-1 binding sites on the IL8
promoter activity [14]. However, site-directed mutagenesis
ofDNAbindingsitesgiveslimitedinformationabouttherole
and importance of transcription factors, particularly where,
as in the IL8 promoter, those sites are close to each other or
overlap. Therefore in an alternative approach we used the
more novel technique of siRNA against AP-1, CEBP, and
NFκB to knock down the expression of their endogenous
proteins. The data generated by siRNA knockdown is
probably the most reliable in terms of the role of individual
transcription factors since it is highly speciﬁc. In addition,
the readout is activity of the endogenous promoter, not a
transfectedconstruct.Incontrasttotheﬁndingfromthesite-
directed mutation studies, basal IL8 levels were not reduced
by knockdown of any of the transcription factors. This may
be because although we achieved 90% knockdown, this was
not complete. However, knockdown of p65 did completely
inhibit the IL1B-stimulated increase in IL8 levels. The eﬀects
of c-Jun and c-Fos knockdown were less marked but still
inhibitory. CEBP knockdown did not inhibit the IL1B-
induced increase in IL8 expression and actually tended to
increaseit.InsomecelltypesCEBPhasbeenshowntoinhibit
the action of NFκB in regulation of IL8. Our knock-out data
suggests that this phenomenon may apply in myometrium.
Certainly our data does not point to a central positive role
for CEBP in driving IL8 expression.
Our data show that, in human myometrial cells, NFκB
is essential for IL8 expression; AP-1 plays a less important
but still stimulatory role, while the role of CEBP is less clear.
The site-directed mutagenesis studies suggested a positive
role in IL8 expression; however, the NFκB and CEBP binding
sites are close together, and it remains possible that mutation
of the CEBP site may have interfered with NFκB binding or
function.TheprobablymorereliabledatafromsiRNAwould
suggest that pharmacological inhibition of CEBP might
enhance IL8 expression and may therefore not be beneﬁcial.
The dominant role played by NFκB in IL8 expression
conﬁrms that it is an attractive therapeutic target for the
prevention of preterm labour.
5. Conclusion
These data show that NFκB is essential for IL8 myometrial
expression, AP-1 plays a less important but still stimulatory
role,whiletheroleofCEBPislessclear.Theseresultsprovide
further support for the notion that NFκB represents an
attractive therapeutic target for the prevention of preterm
labour.
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